Las Vegas ?? New options for the treatment of actinic keratoses (AKs) allow dermatologists to tailor therapy according to patient needs and the lesion characteristics, said Roger I. Ceilley, M.D., at the Fall Clinical Dermatology Conference.
FDA Approves Lebrikizumab-lbkz for Moderate to Severe Atopic Dermatitis
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
April Armstrong, MD, MPH, Shares Insights on the NPF's Psoriasis Health Indicator Report
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Definitions and Diagnostic Criteria of Generalized Pustular Psoriasis Require Continuity, Accuracy, Researchers Report
Comparing Devices to Assess Facial Pigmentary and Inflammatory Conditions